Press-release for stocks related to pharma

tags : Pharma

save search

Total number of shares and voting rights in Zealand Pharma at June 30, 2022
Published: 2022-06-30 (Crawled : 14:00) - globenewswire.com
ZEAL | $13.01 0.23% |

Health Technology

| -2.57% | O: -1.66% H: 0.0% C: 0.0%
pharma

Blueprint Medicines Announces Transformative $1.25 Billion Strategic Financing Collaborations with Sixth Street and Royalty Pharma
Published: 2022-06-30 (Crawled : 12:20) - biospace.com/
RPRX A | $42.75 1.69% 0.24% |

Health Technology

| 0.73% | O: -1.74% H: 1.19% C: 0.84%
BPMC A | $49.87 -1.27% 0.0% |

Health Technology

| -5.26% | O: -0.87% H: 0.19% C: -3.31%
JNJ | News | $179.52 1.13% -0.23% |

Health Technology

| 1.27% | O: -0.29% H: 0.0% C: 0.0%
pharma

Royalty Pharma Acquires Royalty Interest in Gavreto From Blueprint Medicines for up to $340 Million
Published: 2022-06-30 (Crawled : 12:00) - globenewswire.com
BPMC A | $49.87 -1.27% 0.0% |

Health Technology

| -5.26% | O: -0.87% H: 0.19% C: -3.31%
JNJ | News | $179.52 1.13% -0.23% |

Health Technology

| 1.27% | O: -0.29% H: 0.0% C: 0.0%
RPRX A | $42.75 1.69% 0.24% |

Health Technology

| 0.73% | O: -1.74% H: 1.19% C: 0.84%
pharma for

NewAmsterdam Pharma and the Menarini Group Sign Licensing Deal to Commercialize Obicetrapib in Europe
Published: 2022-06-28 (Crawled : 12:20) - biospace.com/
MC | News | $39.66 0.79% 0.0% |

Finance

| -0.43% | O: 0.9% H: 0.82% C: -0.72%
europe pharma deal group

DTx Pharma Appoints Peter Condon as Chief Business Officer
Published: 2022-06-28 (Crawled : 12:00) - biospace.com/
LLY S | $324.71 0.15% 0.11% |

Health Technology

| 0.34% | O: 0.99% H: 0.0% C: 0.0%
pharma

MSP Recovery Commences Billing Big Pharma More Than $5.6 Billion In Billed Amounts and More Than $2.8 Billion In Paid Amounts
Published: 2022-06-28 (Crawled : 02:00) - globenewswire.com
ABBV | $153.8 0.42% -0.09% |

Health Technology

| 0.47% | O: 0.06% H: 1.27% C: -0.44%
LLY S | $324.71 0.15% 0.11% |

Health Technology

| 0.34% | O: 0.99% H: 0.0% C: 0.0%
SNY | News | $50.93 1.8% 1.26% |

Health Technology

| -3.23% | O: -0.27% H: 0.0% C: 0.0%
pharma

ESSA Pharma Presents Clinical Update on EPI-7386 Monotherapy and Combination Therapy Clinical Development
Published: 2022-06-27 (Crawled : 23:00) - biospace.com/
EPIX | $2.83 -10.16% 0.0% |

Health Technology

| -29.5% | O: 2.25% H: 0.0% C: -2.69%
ALPMY | $15.56 |

Manufacturing

| -5.46% | O: -1.2% H: 0.0% C: -0.37%
epi-7386 pharma therapy update

FSD Pharma Inc. Announces Results of Annual General Meeting of Shareholders And Other Corporate Updates
Published: 2022-06-27 (Crawled : 13:00) - biospace.com/
HUGE | $0.76 -3.8% 1.27% |

Process Industries

| -8.22% | O: -7.06% H: 5.15% C: 1.3%
pharma meeting results

BridgeBio Pharma Announces Positive Phase 1 Data and Phase 2/3 Trial Design for BBP-711, a Potentially Best-In-Class GO Inhibitor for Primary Hyperoxaluria Type 1 (PH1) and Recurrent Kidney Stone Formers
Published: 2022-06-27 (Crawled : 12:00) - biospace.com/
BBIO | $9.89 8.92% 2.86% |

Health Technology

| 7.83% | O: 0.22% H: 2.22% C: 1.3%
bbp-711 pharma for kidney trial positive phase 1 potential

Dr. Reddy's Laboratories Announces the Acquisition of an Injectable Product Portfolio from Eton Pharma
Published: 2022-06-24 (Crawled : 16:00) - biospace.com/
ETON | $2.62 0.38% |

Health Technology

| -9.69% | O: 3.81% H: 5.33% C: -1.33%
acquisition pharma

Silo Pharma Expands License Agreement and Patent Portfolio
Published: 2022-06-23 (Crawled : 12:20) - globenewswire.com
SILO | $0.1101 |

Finance and Insurance

| -21.43% | O: -21.57% H: 9.29% C: 9.29%
pharma patent license agreement

invoX Pharma to Acquire F-star Therapeutics, Inc. a Pioneering Next Generation Bispecific Discovery Platform and Clinical Programs
Published: 2022-06-23 (Crawled : 12:00) - biospace.com/
FSTX | $6.3 0.64% -0.32% |

Health Technology

| 67.42% | O: 77.13% H: 0.0% C: -4.5%
MS | $76.75 0.91% 0.3% |

Finance

| 3.96% | O: 0.73% H: 0.0% C: 0.0%
pharma acquire platform

Innate Pharma to Participate in Upcoming Investor Conference - June 23, 2022
Published: 2022-06-23 (Crawled : 07:00) - biospace.com/
SNY | News | $50.93 1.8% 1.26% |

Health Technology

| 2.55% | O: 1.85% H: 0.0% C: 0.0%
NVO | $111.64 0.19% -3.26% |

Health Technology

| 3.98% | O: -0.32% H: 1.34% C: 1.31%
IPHA | News | $2.7 -1.11% |

Health Technology

| 7.41% | O: -1.85% H: 3.02% C: -1.13%
pharma conference

Acasti Pharma Announces Annual Grants of Performance Stock Options
Published: 2022-06-22 (Crawled : 23:00) - globenewswire.com
ACST | $0.8579 -3.25% |

Health Technology

| -7.79% | O: 1.06% H: 2.07% C: 2.07%
pharma grants

China Pharma Announces Receipt of Noncompliance Notice from NYSE American
Published: 2022-06-22 (Crawled : 22:00) - prnewswire.com
CPHI | $0.2142 -0.19% 1.63% |

Health Technology

| -3.03% | O: -1.16% H: 12.21% C: 4.55%
pharma china

MEI Pharma Appoints Human Resources Executive Anne Frese as Chief People Officer
Published: 2022-06-22 (Crawled : 13:00) - biospace.com/
MEIP | News | $0.5799 -4.15% 0.0% |

Health Technology

| 4.43% | O: 3.53% H: 5.93% C: 1.79%
BLCM | News | $1.38 15.97% 0.0% |

Health Technology

| 33.01% | O: 1.94% H: 4.5% C: 3.81%
pharma

BridgeBio Pharma Announces Early Positive Data for BBP-812, its Investigational AAV9 Gene Therapy for Canavan Disease
Published: 2022-06-22 (Crawled : 12:00) - biospace.com/
BBIO | $9.89 8.92% 2.86% |

Health Technology

| 26.21% | O: -1.02% H: 12.96% C: 8.61%
bbp-812 pharma disease for aav9 positive therapy

Athira Pharma Announces Topline Results from ACT-AD Phase 2 Proof of Concept Study of Fosgonimeton in Mild-to-Moderate Alzheimer’s Disease
Published: 2022-06-22 (Crawled : 12:00) - biospace.com/
ATHA P | $3.21 5.25% -1.31% |

Health Technology

| -63.12% | O: -69.76% H: 17.42% C: 7.95%
pharma disease topline alzheimer’s results act-ad phase 2 ath-1017 alzheimer's

Angle PLC Announces Secured Contract From Pharma Services Customer
Published: 2022-06-22 (Crawled : 09:00) - biospace.com/
ANPCF | $1.35 |

Health Technology

| Email alert Add to watchlist
ANPCY | $12.54 |

Manufacturing

| Email alert Add to watchlist
pharma services contract

How to Navigate a Career Change From Pharma to Biotech
Published: 2022-06-21 (Crawled : 15:20) - biospace.com/
JNJ | News | $179.52 1.13% -0.23% |

Health Technology

| 5.24% | O: -0.49% H: 0.0% C: 0.0%
pharma biotech a3ar

← Previous
1
2
3
4
5
6
7
8
9
…
50
51
Next →

tags : Pharma

save search

Your saved searches

Mentioned Today

tags : Pharma save search

Your saved searches

Mentioned Today

tags : Pharma

save search